• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌:核小体、癌胚抗原和 CA19-9 作为凋亡标志物;一项对比研究。

Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study.

机构信息

Faculty of Medicine, Department of Pharmacology and Biochemistry Mu'tah University, Al Karak, Jordan.

出版信息

J Biomed Sci. 2011 Jul 25;18(1):50. doi: 10.1186/1423-0127-18-50.

DOI:10.1186/1423-0127-18-50
PMID:21787404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3150249/
Abstract

BACKGROUND

Colorectal carcinoma is a common and often fatal disease in which methods of early detection and monitoring are essential. The present study was conducted for measuring serum levels of nucleosomes, carcinoembryonic antigen (CEA) and CA 19-9 in patients newly diagnosed with colorectal carcinoma and confirmed by clinicopathological study.

METHOD

Thirty subjects were included in the current study: six normal subjects as a control group with mean age (45.6 ± 7.9) and twenty four colorectal carcinoma patients with mean age (46.9 ± 15.6), which were classified pathologically according to the degree of malignant cell differentiation into well differentiated (group I), moderately differentiated (group II) and poorly differentiated (group III). Fasting venous blood samples were collected preoperative.

RESULTS

The results revealed a significant increase in serum level of nucleosomes in patients with poorly differentiated tumors versus patients with well differentiated tumors (p = 0.041). The levels of CEA and CA19-9 showed no significant increase (p = 0.569 and 0.450, respectively).

CONCLUSION

In conclusion, serum level of nucleosomes provides a highly sensitive and specific apoptotic marker for colorectal carcinoma.

摘要

背景

结直肠癌是一种常见且常致命的疾病,早期检测和监测方法至关重要。本研究旨在测量新诊断为结直肠癌患者的血清核小体、癌胚抗原(CEA)和 CA19-9 水平,并通过临床病理研究进行证实。

方法

本研究纳入 30 名受试者:6 名正常受试者作为对照组,平均年龄(45.6±7.9)岁,24 名结直肠癌患者,平均年龄(46.9±15.6)岁,根据恶性细胞分化程度分为高分化(I 组)、中分化(II 组)和低分化(III 组)。术前采集空腹静脉血样本。

结果

结果显示,低分化肿瘤患者的血清核小体水平显著升高,与高分化肿瘤患者相比(p=0.041)。CEA 和 CA19-9 水平无显著升高(p=0.569 和 0.450)。

结论

总之,血清核小体水平为结直肠癌提供了一种高度敏感和特异的凋亡标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a2/3150249/0f1596dfd155/1423-0127-18-50-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a2/3150249/0f1596dfd155/1423-0127-18-50-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a2/3150249/0f1596dfd155/1423-0127-18-50-1.jpg

相似文献

1
Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study.结直肠癌:核小体、癌胚抗原和 CA19-9 作为凋亡标志物;一项对比研究。
J Biomed Sci. 2011 Jul 25;18(1):50. doi: 10.1186/1423-0127-18-50.
2
Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.癌胚抗原和癌抗原19-9对结直肠癌的诊断价值。
Int J Clin Exp Pathol. 2015 Aug 1;8(8):9404-9. eCollection 2015.
3
Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.评估结直肠癌患者癌胚抗原(CEA)、表皮生长因子受体(EGFR)、上皮细胞粘附分子EpCAM(GA733-2)和糖类抗原19-9(CA 19-9)水平及其与临床病理特征的相关性。
Clin Lab. 2012;58(5-6):441-8.
4
An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.术前血清糖类抗原19-9水平升高是结直肠癌腹膜播散和生存不良的重要预测指标。
Colorectal Dis. 2015 May;17(5):417-25. doi: 10.1111/codi.12865.
5
Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?将术前癌胚抗原(CEA)和糖类抗原19-9(CA19-9)血清水平纳入结直肠癌分期是否合理?
J Surg Res. 2005 Apr;124(2):169-74. doi: 10.1016/j.jss.2004.08.013.
6
Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.术前血清癌胚抗原(CEA)、糖类抗原19-9(CA19-9)和糖类抗原242(CA242)联合检测可改善接受手术治疗的结直肠癌患者的预后预测。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):14853-63. eCollection 2015.
7
Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.糖类抗原 19-9 是癌胚抗原正常的结直肠癌患者的一个有价值的预后因素,它可能有助于预测肺转移。
Int J Colorectal Dis. 2012 Oct;27(10):1333-8. doi: 10.1007/s00384-012-1447-1. Epub 2012 Mar 20.
8
Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.术前血清癌胚抗原、糖类抗原19-9和糖类抗原125作为结直肠癌无复发生存的预后因素。
Asian Pac J Cancer Prev. 2011;12(5):1251-6.
9
Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma.癌抗原(癌胚抗原和糖类抗原19-9)作为结直肠癌晚期的标志物
Med Arch. 2013 Dec;67(6):397-401. doi: 10.5455/medarh.2013.67.397-401. Epub 2013 Dec 28.
10
Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.结直肠癌治疗策略预测生物标志物的比较分析
Ann Surg Oncol. 2007 Apr;14(4):1272-84. doi: 10.1245/s10434-006-9155-0. Epub 2007 Jan 9.

引用本文的文献

1
The diagnostic value of histogram analysis of DWI and DKI for the mismatch repair status of rectal adenocarcinoma.扩散加权成像(DWI)和扩散峰度成像(DKI)直方图分析对直肠腺癌错配修复状态的诊断价值。
Heliyon. 2024 Sep 5;10(18):e37526. doi: 10.1016/j.heliyon.2024.e37526. eCollection 2024 Sep 30.
2
The Importance of Determining Preoperative Serum Concentration of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Assessing the Progression of Colorectal Cancer.在评估结直肠癌的进展中,确定术前血清糖链抗原 19-9 和癌胚抗原浓度的重要性。
Med Arch. 2020 Oct;74(5):346-349. doi: 10.5455/medarh.2020.74.346-349.
3

本文引用的文献

1
The potential of carcinoembryonic antigen, p53, Ki-67 and glutathion Stransferase-π as clinico-histopathological markers for colorectal cancer.癌胚抗原、p53、Ki-67和谷胱甘肽S转移酶-π作为结直肠癌临床组织病理学标志物的潜力。
J Biomed Res. 2010 Jan;24(1):51-7. doi: 10.1016/S1674-8301(10)60008-5.
2
Molecular detection of colorectal neoplasia.结直肠肿瘤的分子检测。
Gastroenterology. 2010 Jun;138(6):2127-39. doi: 10.1053/j.gastro.2010.01.055.
3
Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomas.
Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer.
游离循环甲基化 SEPT9 用于结直肠癌的非侵入性诊断和监测。
Dis Markers. 2018 Apr 23;2018:6437104. doi: 10.1155/2018/6437104. eCollection 2018.
4
Establishment of optimal regulatory network of colorectal cancer based on p42.3 protein.基于p42.3蛋白建立结直肠癌的最佳调控网络。
Saudi J Biol Sci. 2017 Dec;24(8):1781-1786. doi: 10.1016/j.sjbs.2017.11.012. Epub 2017 Nov 9.
5
Establishment of apoptotic regulatory network for genetic markers of colorectal cancer.结直肠癌遗传标志物凋亡调控网络的建立。
Saudi J Biol Sci. 2017 Mar;24(3):466-476. doi: 10.1016/j.sjbs.2017.01.014. Epub 2017 Jan 26.
6
Predictive Value of Carcinoembryonic and Carbohydrate Antigen 19-9 Related to Some Clinical, Endoscopic and Histological Colorectal Cancer Characteristics.癌胚抗原和糖类抗原19-9与某些临床、内镜及组织学结直肠癌特征的预测价值
J Med Biochem. 2016 Sep;35(3):324-332. doi: 10.1515/jomb-2016-0014. Epub 2016 Jul 6.
7
Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.癌胚抗原和癌抗原19-9对结直肠癌的诊断价值。
Int J Clin Exp Pathol. 2015 Aug 1;8(8):9404-9. eCollection 2015.
8
Role of Circulating Cell-Free DNA in Cancers.循环游离DNA在癌症中的作用。
Mol Diagn Ther. 2015 Dec;19(6):339-50. doi: 10.1007/s40291-015-0167-y.
9
Screening of aptamers specific to colorectal cancer cells and stem cells by utilizing On-chip Cell-SELEX.利用芯片上细胞指数富集配体系统筛选结肠癌细胞和干细胞特异性适配体。
Sci Rep. 2015 May 22;5:10326. doi: 10.1038/srep10326.
10
Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in colorectal cancer.术前血清癌胚抗原和糖类抗原 19-9 在结直肠癌中的诊断价值。
Curr Oncol. 2014 Feb;21(1):e1-7. doi: 10.3747/co.21.1711.
用于监测胃肠道癌治疗反应的细胞死亡血清生物标志物。
Eur J Cancer. 2010 May;46(8):1464-73. doi: 10.1016/j.ejca.2010.01.037. Epub 2010 Mar 2.
4
Multiple serological biomarkers for colorectal cancer detection.用于结直肠癌检测的多种血清学生物标志物。
Int J Cancer. 2010 Apr 1;126(7):1683-90. doi: 10.1002/ijc.24912.
5
Programmed cell death pathways and current antitumor targets.程序性细胞死亡途径与当前的抗肿瘤靶点。
Pharm Res. 2009 Jul;26(7):1547-60. doi: 10.1007/s11095-009-9895-1. Epub 2009 Apr 30.
6
Clinical relevance of circulating nucleosomes in cancer.循环核小体在癌症中的临床相关性。
Ann N Y Acad Sci. 2008 Aug;1137:180-9. doi: 10.1196/annals.1448.012.
7
A novel role of serum cytochrome c as a tumor marker in patients with operable cancer.血清细胞色素c作为可手术癌症患者肿瘤标志物的新作用。
J Cancer Res Clin Oncol. 2009 Mar;135(3):371-7. doi: 10.1007/s00432-008-0479-y. Epub 2008 Sep 30.
8
Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review.结直肠癌诊断和治疗延迟与生存的关系:综述
Eur J Cancer. 2007 Nov;43(17):2467-78. doi: 10.1016/j.ejca.2007.08.023. Epub 2007 Oct 10.
9
Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.检测粪便DNA中的异常甲基化作为结直肠癌及癌前病变的分子筛查工具。
World J Gastroenterol. 2007 Feb 14;13(6):950-4. doi: 10.3748/wjg.v13.i6.950.
10
Colorectal cancer screening in the elderly population: disparities by dual Medicare-Medicaid enrollment status.老年人群中的结直肠癌筛查:医疗保险与医疗补助双重参保状态导致的差异
Health Serv Res. 2006 Dec;41(6):2136-54. doi: 10.1111/j.1475-6773.2006.00585.x.